Carotid Endarterectomy (CEA) performed in combination with coronary artery bypass grafting (CABG) have also increased steadily since Bernhard and colleague's initial report in 1972. Coexistence of symptomatic coronary artery disease and significant carotid artery stenosis ranges from 3.4% to 22%. The incidence of postoperative stroke after CABG ranges from 0.7% to 5%. Coronary revascularization in a patient with internal carotid artery stenosis more than 50% is associated with a postoperative stroke rate of 6%, which increases significantly to more than 16% when stenosis is more than 90%. To reduce the potential risk for postoperative stroke after CABG in patients with significant or symptomatic carotid artery stenosis, many surgeons have advocated combined CABG with unilateral carotid endarterectomy. However, clinical experience with the concomitant approach is conflicting. On the basis of the long-term results, it is estimated that simultaneous carotid endarterectomy and myocardial revascularization in conjunction with cardiopulmonary bypass is a method safe enough to prefer its routine use with acceptable low operative risk and satisfactory long-term morbidity. The overall 30-day mortality of combined CABG with bilateral carotid endarterectomy was 6.1% and that was unrelated to primary cardiac or cerebrovascular events. Favorable outcome also supports the justification for performing concomitant coronary artery bypass grafting with bilateral carotid endarterectomies in selected patients.
Introduction
Carotid endarterectomy (CEA) is a surgical procedure that was introduced in the early 1950s and is performed in both symptomatic and asymptomatic patients. The safety and efficacy of carotid endarterectomy as a strategy for stroke prevention has long been debated and given rise to unresolved controversy. In response to genuine concerns expressed by many investigators, considerable effort has resulted in publication of retrospective reviews, natural history studies, audits of community practice, position papers by various societies, expert opinion statements, and finally prospective randomized trials designed to address specific issues and indications for surgery.
Several clinical trials were instrumental in establishing CEA as a superior treatment over medical management in the prevention of stroke.
NASCET, or the North American Symptomatic Carotid Endarterectomy trial, enrolled 2885 symptomatic patients who were randomized over 9 years from December 1987 to December 1996. Symptomatic patients were described as those with non-disabling stroke or transient ischemic attack within 180 days prior to enrollment in the study. Patients had varying degrees of carotid stenosis by angiography and lesions were categorized as follows: 1) low, moderate stenosis (<50%), 2) moderate stenosis (50-69%), and 3) severe stenosis (70-99%). Patients were assigned to either CEA and best medical management or best medical management alone. The latter entailed antiplatelet therapy (usually aspirin) and risk factor modification if indicated. 1 In February 1991, approximately 3 years after the trial began; enrollment in the severe stenosis group (70-99%) was discontinued due to overwhelming evidence in favor of CEA as a superior treatment. The results showed that a cumulative risk of any ipsilateral stroke at two years was 26% for the medical management patients, and only 9% for the surgical patients; an absolute difference of 17.0±3.5% (p<0.001). 2 Further analysis indicated that, while the greatest benefit of CEA was demonstrated in the NASCET patients with severe stenosis, the superiority of CEA over medical therapy was also demonstrated in patients with moderate stenosis (50-69%). In this group, the 5-year rate of ipsilateral stroke was 15.7% in the surgical group and 22.2% in the medical group (p=0.045). 1 Two major trials examined the benefits of CEA in the asymptomatic patient population.
The Asymptomatic Carotid Atherosclerosis Study (ACAS) randomized 1,662 asymptomatic patients with >60% stenosis by angiography. Enrollment occurred from December 1987 to December 1993. Patients assigned to the medical management group received aspirin daily as well as risk factor management. After a median follow-up of 2.7 years, it was estimated that the aggregate risk of ipsilateral stroke over 5 years and any perioperative stroke or death was 5.1% in the CEA group and 11% in the medical management group. The aggregate risk reduction was 53% (p=0.004). 3 The Veterans Affairs Cooperative Study (VACS) enrolled 22 asymptomatic men from 1983 to 1991 who had at least 50% carotid stenosis by angiography. All patients, regardless of randomization, received 650 mg of ASA twice a day. When neurological endpoints were determined for the entire duration of the trial, patients treated with CEA had an 8% overall rate of ipsilateral neurological events (TIA, monocular blindness, stroke) compared with 20.6% for the medical management group (p<0.001). For ipsilateral stroke alone throughout the course of the trial, the rates were 4.7% for the surgical group and 9.4% for the medical group, demonstrating a trend, though not statistically significant, towards superiority of CEA. 4 This trial demonstrated that CEA significantly reduced the incidence of neurological events as compared to those treated medically. The data from these randomized trials provided information that assisted an ad hoc committee of the American Heart Association (AHA) in issuing guidelines for endarterectomy in 1995 with an update in 1998. 5 Recommendations were given for both symptomatic and asymptomatic patients with carotid artery disease. For each indication there is a stated surgical risk that is a combined estimate of the patient's medical fitness for surgery along with the surgeon's risk of morbidity and mortality for the surgical procedure. Surgical risk categories range from 3% to 10%. Under the current AHA guidelines, recommendations for CEA in the asymptomatic population are generally for high-grade lesions (>60%) in patients with relatively good health. For symptomatic patients, CEA is recommended for patients with recent cerebrovascular ischemic event who have at least 50% stenosis in the carotid artery.
Reports of carotid endarterectomy (CEA) performed in combination with CABG have also increased steadily since Bernhard and colleague's initial report of 16 such cases in 1972. 6 Coexistence of symptomatic coronary artery disease and significant carotid artery stenosis ranges from 3.4% to 22%. 7 In the past two decades, the high-risk potential for neurologic dysfunction after coronary artery bypass grafting (CABG) in patients with concomitant carotid stenosis has been a real challenge for surgeons in terms of determining which operative sequence offers the highest freedom from cardiac or cerebral complications. In general, the incidence of postoperative stroke after CABG ranges from 0.7% to 5%. 7, 8 Coronary revascularization in a patient with internal carotid artery stenosis more than 50% is associated with a postoperative stroke rate of 6%, which increases significantly to more than 16% when stenosis is more than 90%. [9] [10] [11] [12] [13] To reduce the potential risk for postoperative stroke after CABG in patients with significant or symptomatic carotid artery stenosis, many surgeons have advocated combined CABG with unilateral carotid endarterectomy. However, clinical experience with the concomitant approach is conflicting. 9, 11, 14 Biases in patient selection criteria, variations in operative techniques, and intraoperative cerebral protective measures may help to explain a wide range of postoperative stroke rate (from 2% to 20%) associated with the combined approach.
In Canada, 0.51% of CABG procedures were combined CEA-CABG. The adjusted stroke and death rate was 2.67-fold greater in the combined CEA-CABG group compared to CABG alone. 15 Another study in USA, determined hospital mortality and postoperative stroke rates after combined carotid endarterectomy (CEA) and coronary artery bypass graft surgery (CABG) versus CABG alone, using the US Nationwide Inpatient Sample. The mortality rate in CEA-CABG combined was 1.06%. After correcting for comorbidities, the odds ratio for postoperative stroke or death for CEA-CABG was 1.38 (95% CI 1.27 to 1.50) versus CABG alone. Guided by the increase in postoperative stroke and death, this survey advocated a randomized, controlled clinical trial of combined CEA-CABG. 16 Though concurrent Carotid Endarterectomy (CEA) and Coronary Artery Bypass Graft (CABG) is associated with an increased incidence of stroke and death compared to isolated CABG, it is unclear whether this reflects two concurrent operative procedures or the increased risk in patients with more extensive atherosclerosis. To address this question a case controlled study was performed using data from the New York State Cardiac Database from 1997-1998. Patients who underwent combined CEA-CABG were compared to all isolated CABG patients and a risk matched cohort of isolated CABG patients. The 35,539 isolated CABG patients had fewer post operative complications than the 744 combined CEA-CABG patients, but also had a lower overall risk profile. After propensity matching for confounding variables, no differences in length of stay, stroke, myocardial infarction, were male, as compared with 68 years and 68% (68/100) male in the combined group; median age of the coronary bypass cohort was 65 years and 76% (381/500) male. A significantly higher percentage of patients in the coronary bypass versus combined group were in New York Heart Association functional class IV. In the combined group there was a significantly higher incidence of older age, diabetes, hypertension, hyperlipidemia renal failure, and congestive heart failure. There was no difference among the three groups with respect to hospital mortality (0%, 3.4%, and 4.0%, respectively) and permanent stroke (0.7%, 1.2%, and 0%, respectively). Hospital costs were $4,896, $10,959 and $11,089, respectively, with a savings of $4,766 (30%), and Medicare hospital reimbursement was $8,575, $23,071, and $23,071, respectively, with a savings of $10,077 (25.3%). Thus, in appropriate patients, a combined procedure is cost effective, eliminating a second surgical procedure cost of the postoperative stay (3.7 ± 2.4 days) associated with isolated carotid endarterectomy. Risk of permanent stroke or death is not increased. 18 Coronary artery bypass grafting (CABG) is conventionally performed utilizing cardiopulmonary bypass (CPB), aortic cross clamping, and cardioplegic cardiac arrest. However, CABG without CPB i.e. off-pump CABG (OP-CABG) is now practiced widely and is an accepted technique of myocardial revascularization. Off-pump CABG eliminates the systemic inflammatory response syndrome (SIRS) associated with CPB and is shown to be associated with significantly less myocardial damage as compared to CABG with CPB. A combined CEA and CABG performed as a one-stage procedure offers better overall outcome than a two-stage approach. Traditionally, cerebral perfusion during CEA is maintained by the use of shunts inserted into the proximal and distal carotid arteries. An alternative method of maintaining carotid perfusion during combined carotid endarterectomy and off-pump coronary artery bypass grafting involves insertion of a cannula in the ascending aorta after a median sternotomy. This cannula is connected to a perfusion cannula, the distal end of which is inserted into the carotid artery beyond the carotid arteriotomy. This technique of aorticocarotid shunting and carotid perfusion was utilized in nine patients who underwent successful combined carotid endarterectomy and off-pump coronary artery bypass grafting. 19 A retrospective nonrandomized chart review was performed in 33 patients with unstable angina and bilateral carotid artery stenosis, more than 70%, undergoing simultaneous coronary artery bypass grafting and bilateral carotid endarterectomy using an eversion technique. Concomitant coronary artery bypass grafting with bilateral carotid endarterectomy was performed urgently in 24 (73%) and electively in 9 (27%) patients. The average carotid artery cross-clamp and total perfusion times were 14.7 ± 4.9 minutes and 123 ± 29.2 minutes, respectively. The average length of stay in the cardiopulmonary intensive care unit was 4.2 ± 14.2 days and total hospital stay was 16.2 ± 20.5 days. Postoperative in-hospital stay was 14.9 ± 20.3 days. There were no postoperative strokes. Twenty-one (64%) patients were discharged before the tenth postoperative day. Nonfatal postoperative complications occurred in 27% (9 of 33) of patients. The overall 30-day mortality was 6.1% (2 of 33) and that was unrelated to primary cardiac or cerebrovascular events. Favorable outcome supports the justification for performing concomitant coronary artery bypass grafting with bilateral carotid endarterectomies in selected patients. 20 Another study involving 340 patients who underwent simultaneous carotid endarterectomy and myocardial revascularization from February 1985 to September 1998 was reviwed. The average age of the patients was 65.3 years; 45.6% were neurologically symptomatic, and 44.4% had bilateral carotid stenosis. The indication for carotid endarterectomy was lumen diameter reduction of more than 75%, angiographic signs of thrombogenic endovascular morphology, or both. Carotid endarterectomy was performed in conjunction with cardiopulmonary bypass with mild hypothermia, hemodilution, systemic heparinization, and controlled hemodynamics under pulsatile perfusion for additional cerebral protection. There were 16 perioperative neurologic complications (4.7%), 11 permanent deficits (3.2%), and 9 cardiac complications (2.6%). Early mortality was 2.6% (SE 0.8%): 2 patients had a stroke and 2 had a myocardial infarction. The 5-year survival was 78.9% (SE 2.6%), and freedom from ipsilateral stroke and cardiac event were 93.2% (SE 1.5%) and 87.5% (SE 2.1%), respectively. The predictor for early death was age over 70 years, and predictors for late death were age over 70 years, previous myocardial infarction, previous stroke, and bilateral carotid stenosis of greater than 90%. On the basis of the long-term results, it is estimated that simultaneous carotid endarterectomy and myocardial revascularization in conjunction with cardiopulmonary bypass is a method safe enough to prefer its routine use with acceptable low operative risk and satisfactory long-term morbidity. 21 
Conclusion
Various studies proved that combined carotid endarterectomy and coronary artery bypass grafting is a cost effective and safe procedure and does not increase overall morbidity and mortality and can be used in selected group of patients.
